SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr |
What is the latest Contingent Liabilities ratio of SAMRAT PHARMACHEM ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹0.07 Cr |
| Mar2023 | ₹0.07 Cr |
| Mar2022 | ₹0.07 Cr |
| Mar2021 | ₹0.07 Cr |
How is Contingent Liabilities of SAMRAT PHARMACHEM Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹0.07 Cr | 0.00 | |
| Mar2023 | ₹0.07 Cr | 0.00 | |
| Mar2022 | ₹0.07 Cr | 0.00 | |
| Mar2021 | ₹0.07 Cr | - | |
Compare Contingent Liabilities of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹69.7 Cr | 8.1% | 6.1% | -31.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | 8.1% |
6.1% |
-31.4% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses